The Prognostic Importance of Changes in CD4^+Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral Therapy
- 17 February 2004
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 140 (4) , 256-264
- https://doi.org/10.7326/0003-4819-140-4-200402170-00007
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.Archives of internal medicine (1960), 2002
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesThe Lancet, 2002
- Evaluation of the Effectiveness of Highly Active Antiretroviral Therapy in Persons with Human Immunodeficiency Virus using Biomarker-based Equivalence of Disease ProgressionAmerican Journal of Epidemiology, 2002
- Effectiveness of highly active antiretroviral therapy among HIV-1 infected womenJournal of Epidemiology and Community Health, 2002
- A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA StudyThe Journal of Infectious Diseases, 2002
- Use of Highly Active Antiretroviral Therapy in a Cohort of HIV-Seropositive WomenAmerican Journal of Public Health, 2002
- Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug TherapyJAMA, 2001
- Declining HIV/AIDS Mortality in New York CityJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Guideline for flow cytometric immunophenotyping: A report from the national institute of allergy and infectious diseases, division of AIDSCytometry, 1993